
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152538178AF1D9A3053817006B5B852E.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="springeropen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Clinical &amp; Experimental Metastasis">
<meta name="citation_title" content="Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis">
<meta name="citation_author" content="Sofia Halin Bergström">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Julius Semenas">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Annika Nordstrand">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Elin Thysell">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Johan Wänman">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Orthopedics, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Sead Crnalic">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Orthopedics, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Anders Widmark">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Camilla Thellenberg-Karlsson">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Pernilla Andersson">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Urology and Andrology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Susanne Gidlund">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Marie Lundholm">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Karin Welén">
<meta name="citation_author_institution" content="Department of Urology, Sahlgrenska Centre for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden">
<meta name="citation_author" content="Andreas Josefsson">
<meta name="citation_author_institution" content="Department of Diagnostics and Interventions, Urology and Andrology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Pernilla Wikström">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_author" content="Anders Bergh">
<meta name="citation_author_institution" content="Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="42">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="49">
<meta name="citation_doi" content="10.1007/s10585-025-10365-y">
<meta name="citation_pmid" content="40841830">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/pdf/10585_2025_Article_10365.pdf">
<meta name="description" content="We previously identified three molecular subtypes of prostate cancer (PC) bone metastases, MetA-C, with MetB linked to poor prognosis after androgen deprivation therapy (ADT). This study analyzed epithelial and stromal markers using ...">
<meta name="og:title" content="Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="We previously identified three molecular subtypes of prostate cancer (PC) bone metastases, MetA-C, with MetB linked to poor prognosis after androgen deprivation therapy (ADT). This study analyzed epithelial and stromal markers using ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370827">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s10585-025-10365-y"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/10585_2025_Article_10365.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370827%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370827/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370827/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-springeropen.png" alt="Springer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Springer" title="Link to Springer" shape="default" href="https://doi.org/10.1007/s10585-025-10365-y" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Clin Exp Metastasis</button></div>. 2025 Aug 21;42(5):49. doi: <a href="https://doi.org/10.1007/s10585-025-10365-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s10585-025-10365-y</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Clin%20Exp%20Metastasis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clin%20Exp%20Metastasis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Clin%20Exp%20Metastasis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Clin%20Exp%20Metastasis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Halin%20Bergstr%C3%B6m%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Sofia Halin Bergström</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Sofia Halin Bergström</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Halin%20Bergstr%C3%B6m%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sofia Halin Bergström</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Semenas%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Julius Semenas</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Julius Semenas</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Semenas%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julius Semenas</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nordstrand%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Annika Nordstrand</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Annika Nordstrand</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nordstrand%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Annika Nordstrand</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thysell%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Elin Thysell</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Elin Thysell</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thysell%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elin Thysell</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A4nman%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Johan Wänman</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Johan Wänman</span></h3>
<div class="p">
<sup>2</sup>Department of Diagnostics and Interventions, Orthopedics, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A4nman%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Johan Wänman</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Crnalic%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Sead Crnalic</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Sead Crnalic</span></h3>
<div class="p">
<sup>2</sup>Department of Diagnostics and Interventions, Orthopedics, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Crnalic%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sead Crnalic</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Widmark%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Anders Widmark</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Anders Widmark</span></h3>
<div class="p">
<sup>3</sup>Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Widmark%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anders Widmark</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thellenberg-Karlsson%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Camilla Thellenberg-Karlsson</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Camilla Thellenberg-Karlsson</span></h3>
<div class="p">
<sup>3</sup>Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thellenberg-Karlsson%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Camilla Thellenberg-Karlsson</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Andersson%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Pernilla Andersson</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Pernilla Andersson</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">
<sup>5</sup>Department of Diagnostics and Interventions, Urology and Andrology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Andersson%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pernilla Andersson</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gidlund%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Susanne Gidlund</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Susanne Gidlund</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gidlund%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Susanne Gidlund</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lundholm%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Marie Lundholm</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Marie Lundholm</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lundholm%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marie Lundholm</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wel%C3%A9n%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Karin Welén</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Karin Welén</span></h3>
<div class="p">
<sup>4</sup>Department of Urology, Sahlgrenska Centre for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wel%C3%A9n%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Karin Welén</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Josefsson%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Andreas Josefsson</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Andreas Josefsson</span></h3>
<div class="p">
<sup>5</sup>Department of Diagnostics and Interventions, Urology and Andrology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Josefsson%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andreas Josefsson</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wikstr%C3%B6m%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Pernilla Wikström</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Pernilla Wikström</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wikstr%C3%B6m%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pernilla Wikström</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bergh%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Anders Bergh</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Anders Bergh</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bergh%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anders Bergh</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden </div>
<div id="Aff2">
<sup>2</sup>Department of Diagnostics and Interventions, Orthopedics, Umeå University, Umeå, Sweden </div>
<div id="Aff3">
<sup>3</sup>Department of Diagnostics and Interventions, Oncology, Umeå University, Umeå, Sweden </div>
<div id="Aff4">
<sup>4</sup>Department of Urology, Sahlgrenska Centre for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden </div>
<div id="Aff5">
<sup>5</sup>Department of Diagnostics and Interventions, Urology and Andrology, Umeå University, Umeå, Sweden </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 10; Accepted 2025 Jul 2; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370827  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841830/" class="usa-link">40841830</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">We previously identified three molecular subtypes of prostate cancer (PC) bone metastases, MetA-C, with MetB linked to poor prognosis after androgen deprivation therapy (ADT). This study analyzed epithelial and stromal markers using immunohistochemistry, focusing on their relationship to MetA-C subtypes, spatial heterogeneities, and clinical outcomes after ADT. High tumor proliferation and low PSA expression were associated with MetB and poor outcomes after ADT. Most metastases contained tumor epithelial subclones with different morphologies. In the metastasis stroma, blood vessels and fibroblast-like cells expressed smooth muscle actin (SMA), platelet-derived growth factor β, stroma-derived factor 1 (SDF1), periostin (POSTN), and decorin (DCN). Compared to each other, MetB metastases had higher SMA and ERG + endothelial cell densities, while MetA cases showed higher SDF1 and DCN levels. Accordingly, high POSTN and ERG + densities were associated with poor outcomes after ADT, whereas high DCN indicated favorable prognosis. Low levels of AR-positive stromal cells were linked to poor outcomes. Macrophage and T-lymphocyte densities showed no significant associations with metastases subtypes or outcome. Two stroma subtypes were identified: subtype 1 with higher bone content, lower vessel density, MetA-enrichment and better prognosis compared to subtype 2 that exhibited higher tumor proliferation and lower PSA expression. Most metastases contained regions of both stroma subtypes.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s10585-025-10365-y.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Prostate cancer metastases, Bone metastasis stroma, Metastatic stroma , Prostate cancer molecular subtypes, Tumor heterogeneity, Stromal markers, Metastases morphology, Tumor microenvironment, Androgen deprivation therapy</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Cancers confined to the prostate can be cured with surgery or radiotherapy. However, the presence of clinically detectable bone metastases often indicates a lethal stage of the disease. Current treatments for bone metastatic prostate cancer (PC), which target androgen synthesis (androgen deprivation therapy, ADT) and/or androgen receptor (AR) signaling, along with taxanes, provide only temporary relief [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>], highlighting the need for more effective treatments. Clinical observations and experimental studies suggest that tumor response to ADT is stronger in the prostate than in the bone [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However, the underlying reasons for this differential response remain poorly understood. Further research is needed to explore the insufficient ADT response in metastases and the factors involved, including the role of the metastatic microenvironment.</p>
<p id="Par3">The global transcriptome, proteome, and morphology show distinct differences between primary tumors and metastases [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Additionally, PC bone metastases can be divided into subgroups based on biological characteristics, morphology and clinical outcomes [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>–<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Based on transcriptomic differences, PC bone metastases can be classified into three subgroups: MetA, MetB, and MetC [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. MetA (~ 70% of cases) shows high expression of androgen-regulated genes, including KLK3 (PSA), and MetA patients have relatively good prognosis after ADT and AR-targeted therapies. MetB (~ 20% of cases), the most aggressive subtype, is characterized by high cell proliferation, a dedifferentiated luminal cell phenotype, low PSA, and poor prognosis after ADT. MetC, a small subgroup (~ 10% of cases), is associated with high stroma-related gene expression, low PSA, and intermediate prognosis.</p>
<p id="Par4">The distinct gene expression patterns of the MetA-C subtypes suggest that different mechanisms, including varying stroma-epithelial interactions, might drive their behavior, such as treatment response, disease progression, and overall prognosis [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Stroma-epithelial interactions are known to influence primary PC growth and treatment response [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. However, the relationship between attenuated efficacy of ADT therapy in bone metastases and the specific cell types present in the bone metastasis microenvironment [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] remains underexplored.</p>
<p id="Par5">The most contrasting metastasis subtypes, MetA and MetB, can be identified using two immunohistochemical markers: Ki67 for tumor cell proliferation and PSA for luminal cell differentiation and androgen receptor (AR) activity [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. High Ki67 and low PSA levels indicate a dominating MetB signature, while MetA metastases show the opposite pattern [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Gene expression analysis also suggests that most bone metastases are heterogeneous for MetA-C subtypes and that increased fraction of cells with MetB characteristics is a strong negative prognostic factor [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. This raises the possibility that spatial variations in metastasis morphology and ADT response exist.</p>
<p id="Par6">This study aimed to characterize morphological heterogeneities in the epithelial and stromal compartments of human PC bone metastases and to investigate their relationship with the transcriptomic subtypes MetA-C and patient outcome following ADT. We quantified immunohistochemical markers specific to epithelial and stromal cells, assessed bone content and overall stroma morphology, and evaluated marker heterogeneity within metastasis samples. Furthermore, we analyzed the associations between epithelial and stromal markers, morphology, MetA-C subtypes, and outcomes following ADT. Lastly, we compared the expression levels of these markers across three patient groups: untreated patients, those on short-term ADT, and patients with CRPC.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec6"><h3 class="pmc_sec_title">Patients</h3>
<p id="Par7">The study includes 167 patients with metastatic PC from whom metastatic tissue samples were available (Table <a href="#Tab1" class="usa-link">1</a>). In most cases, the metastatic tissue was obtained during surgery due to metastatic spinal cord compression (<em>n</em> = 138) or pathological hip fractures (<em>n</em> = 13) at Umeå University Hospital or at the Sahlgrenska University Hospital between 2003 and 2021. In other cases, core biopsies were obtained during treatment for castration-resistant PC (CRPC) from the iliac crest (<em>n</em> = 15) or rib (<em>n</em> = 1) metastases. At the time of sampling, patients were either hormone-naïve (<em>n</em> = 30), castration-resistant (<em>n</em> = 121), or treated with ADT for a short period ranging between 1 and 22 days (short-term castrated, <em>n</em> = 16). All patients gave their informed consent, and the study was conducted in accordance with the Declaration of Helsinki. The study was approved by the local ethic review boards of Umeå University (Dnr 03-158 with amendments Dnr 04-26 M, Dnr 2013-57-31 M) and Gothenburg (Dnr 455 − 11 with amendment 2019–05732).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinical characteristics of 167 patients with bone metastasis tissue samples explored for morphological markers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Median (25th; 75th percentiles)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age diagnosis (yrs.)</td>
<td align="left" colspan="1" rowspan="1">70 (65; 76)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age metastasis sampling (yrs.)</td>
<td align="left" colspan="1" rowspan="1">73 (68; 78)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Serum PSA diagnosis (ng/ml)</td>
<td align="left" colspan="1" rowspan="1">91 (26; 700)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Serum PSA metastasis sampling (ng/ml)</td>
<td align="left" colspan="1" rowspan="1">160 (44; 800)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Follow-up from diagnosis (yrs.)</td>
<td align="left" colspan="1" rowspan="1">3.9 (2.0–7.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Follow-up from ADT (yrs.)</td>
<td align="left" colspan="1" rowspan="1">3.5 (2.0–6.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Follow-up from metastasis surgery (yrs.)</td>
<td align="left" colspan="1" rowspan="1">1.0 (0.32–2.6)</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Metastasis site</th>
<th align="left" colspan="1" rowspan="1">N (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Spine</td>
<td align="left" colspan="1" rowspan="1">138 (83)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Iliac crest</td>
<td align="left" colspan="1" rowspan="1">15 (9.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hip</td>
<td align="left" colspan="1" rowspan="1">13 (7.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Rib</td>
<td align="left" colspan="1" rowspan="1">1 (0.6)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Castration therapy<sup>a</sup>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> None (hormone-naïve)</td>
<td align="left" colspan="1" rowspan="1">30 (18%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Short-term<sup>b</sup>
</td>
<td align="left" colspan="1" rowspan="1">16 (9.6%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Long-term</td>
<td align="left" colspan="1" rowspan="1">121 (73%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Treatment for CRPC</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Palliative radiation (towards metastasis)</td>
<td align="left" colspan="1" rowspan="1">23/121</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Bicalutamide</td>
<td align="left" colspan="1" rowspan="1">56/118</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Chemotherapy</td>
<td align="left" colspan="1" rowspan="1">33/121</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Abiraterone acetate</td>
<td align="left" colspan="1" rowspan="1">12/121</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Enzalutamide</td>
<td align="left" colspan="1" rowspan="1">4/121</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ra223</td>
<td align="left" colspan="1" rowspan="1">3/121</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Zoledronic acid/Denosumab</td>
<td align="left" colspan="1" rowspan="1">5/121</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p12"><p>Continuous variables given as median (25th; 75th percentiles). <sup>a</sup>Castration therapies given prior to collection of metastasis tissue samples included surgical ablation, LHRH/GnRH agonist therapy or bicalutamide treatment. <sup>b</sup>Short-term treatment for 1–22 days before metastasis tissue sampling.</p></div></div></section></section><section id="Sec7"><h3 class="pmc_sec_title">Morphology and immunohistochemical analysis</h3>
<p id="Par9">Formalin-fixed paraffin-embedded (FFPE) metastasis tissue samples were stained with hematoxylin and eosin for morphological evaluation of growth pattern involving stromal subtype, bone (woven + lamellar) density, and apoptosis. Using the automated Ventana BenchMark Ultra platform (Ventana Medical systems), sections were stained for: PSA (Dako, #A0562, 1:1000), Ki67 (Ventana, #790–4286, clone 30 − 9, Ready-to-use (RTU)), AR (Biogenex, #MU256-UC, clone F39.4.1, 1:50), CHRA (Ventana, #760–2519, clone LK2H10, RTU), SMA (Dako, #M0851, clone 1A4, 1:150), POSTN (Atlas, #HPA012306, 1:100), DCN (Atlas, #HPA003315, 1:500), CD68 (Dako, #M0814, clone KP1, 1:2000), or CD3 (Ventana, #790–4341, clone 2GV6, RTU), with Ultra Cell conditioning 1 (CC1) as antigen retrieval buffer and developed with the UltraView Universal DAB Detection kit (PSA, Ki67, CHRA, SMA, POSTN, DCN, CD68) or the OptiView DAB IHC Detection kit (AR, CD3). ERG (Biocare Medical, #CM421A, clone 9FY, 1:50), PDGFRB (Cell Signaling, #3169S, clone 28E1, 1:75), and SDF1 (R&amp;D Systems, MAB350, clone 79018, 1:50) were stained manually with antibodies incubated overnight at + 4 °C, Tris-EDTA pH 9 was used as antigen retrieval. The detection system MACH3 Mouse HRP-Polymer kit (Biocare Medical) was used for ERG and SDF1, and a biotinylated goat anti-rabbit and the Vectastain ABC-HRP kit (Vector Laboratories) were used for PDGFRB. All sections were developed with DAB.</p>
<p id="Par10">The PSA and AR staining in tumor epithelial cells were quantified using a scoring system based on the percentage (0: 0%, 1: 1–25%, 2: 26–50%, 3: 51–75%, and 4: 76–100%) and intensity (0: negative, 1: week, 2: moderate, and 3: intense staining) of immunostained cells. An immunoreactivity (IR) score was obtained by multiplying the scores for distribution and intensity, giving IR scores in the range of 0–12. Ki67 and CHRA in tumor epithelial cells were quantified as the percentage of stained tumor cells, evaluated in 500–1000 cells per patient. Tumor cells were also scored as ERG positive or ERG negative. The volume density of SMA + stroma, PDGFRB + stroma, SDF-1 + stroma, POSTN + stroma, DCN + stroma, ERG + endothelial cells, CD68 + macrophages, and CD3 + T-lymphocytes, was quantified using a square-lattice mounted in the eyepiece of the microscope counting grid-intersection falling on the stained tissue component and on reference space. Similarly, the density of bone was quantified on hematoxylin–eosin-stained sections. The fraction of apoptotic epithelial cells was scored in at least 1000 cells per sample as earlier described [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The fraction of stroma cells positive for AR and for Ki67 was calculated after examining approximately 1000 stroma cells per sample.</p>
<p id="Par11">Chromogenic double staining was performed on the automated Ventana Discovery Ultra platform (Ventana Medical systems), except for double staining with ERG. Here, automated staining was preceded by manually stained ERG (see above). Antibodies used were the same as for single staining (see above and Table <a href="#Tab2" class="usa-link">2</a> for more details). Ultra CC2 was used for antibody denaturation (100°C, 8′) and Discovery Inhibitor was used for blocking of endogenous peroxidase (8′). Hematoxylin II (4′) and Bluing (4′) were used as counterstain.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Protocol parameters for discovery ultra chromogenic double-staining</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">PSA/Ki67</th>
<th align="left" colspan="1" rowspan="1">ERG/PDGFRB</th>
<th align="left" colspan="1" rowspan="1">ERG/SMA</th>
<th align="left" colspan="1" rowspan="1">ERG/DCN</th>
<th align="left" colspan="1" rowspan="1">ERG/POSTN</th>
<th align="left" colspan="1" rowspan="1">ERG/SDF1</th>
<th align="left" colspan="1" rowspan="1">DCN/PDGFRB</th>
<th align="left" colspan="1" rowspan="1">DCN/SMA</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Antibody (dilution, minutes)</td>
<td align="left" colspan="1" rowspan="1">PSA (1:1000, 32′)</td>
<td align="left" colspan="1" rowspan="1">ERG (manual staining)</td>
<td align="left" colspan="1" rowspan="1">ERG (manual staining)</td>
<td align="left" colspan="1" rowspan="1">ERG (manual staining)</td>
<td align="left" colspan="1" rowspan="1">ERG (manual staining)</td>
<td align="left" colspan="1" rowspan="1">ERG (manual staining)</td>
<td align="left" colspan="1" rowspan="1">PDGFRB (1:75, 60′)</td>
<td align="left" colspan="1" rowspan="1">SMA (1:100, 32′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antigen retrieval (temperature, minutes)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">Ultra CC1 (95 °C, 64′)</td>
<td align="left" colspan="1" rowspan="1">Ultra CC1 (95 °C, 32′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Multimer (minutes)</td>
<td align="left" colspan="1" rowspan="1">UMap anti-Rb AP (16′)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, (16′)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Ms HRP (16′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chromogen (minutes)</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Yellow (44′)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple (32′)</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple (32′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antibody (dilution, minutes)</td>
<td align="left" colspan="1" rowspan="1">Ki67 (RTU, 32′)</td>
<td align="left" colspan="1" rowspan="1">PDGFRB (1:50, 60′)</td>
<td align="left" colspan="1" rowspan="1">SMA (1:100, 32′)</td>
<td align="left" colspan="1" rowspan="1">DCN (1:500, 32′)</td>
<td align="left" colspan="1" rowspan="1">POSTN (1:150, 32′)</td>
<td align="left" colspan="1" rowspan="1">SDF1 (1:50, 32′)</td>
<td align="left" colspan="1" rowspan="1">DCN (1:200, 32′)</td>
<td align="left" colspan="1" rowspan="1">DCN (1:200, 32′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Antigen retrieval (temperature, minutes)</td>
<td align="left" colspan="1" rowspan="1">CC1 (95 °C, 64′)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">Ultra CC1 (95 °C, 16′)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Multimer (minutes)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP (16′)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, (16′)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Ms HRP, (16′)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, (16′)</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, 16′</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Ms HRP, 16′</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, 20′</td>
<td align="left" colspan="1" rowspan="1">OMap anti-Rb HRP, 20′</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chromogen (minutes)</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Purple 32′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Yellow HRP 32′ + 16′</td>
<td align="left" colspan="1" rowspan="1">DISCOVERY Yellow HRP 32′ + 16′</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par13">To perform multiplex immunofluorescence analysis, we used the Opal Fluorophore reagent packs (Akoya Biosciences) and the Discovery Ultra platform (Ventana Medical Systems). Slides were manually deparaffinized, rehydrated and pre-treated with Tris/EDTA pH 9. Sequential repetitive cycles of primary antibody, secondary HRP antibody followed by Opal Fluorophore were performed for each antibody; (1) SDF1 (1:25, 1 h; OMap-Ms, 16′; O-520, 1:50, 32′), (2) PDGFRB (1:75, 1 h; OMap-Rb, 16′; O-570, 1:100, 20′), (3) DCN (1:300, 1 h; OMap-Rb, 16′; O-620, 1:100, 20′), (4) SMA (1:100, 32′; OMap-Ms, 16′; O-650, 1:50, 20′), and (5) Pan-Cytokeratin AE1/AE3 (DAKO, #M3515) (1:50, 32′; OMap-Ms, 16′; O-690, 1:50, 20′). For antibody denaturation, Ultra CC2 was used between each cycle (100 °C, 8′). To quench endogenous peroxidase the first sequence was preceded by Discovery Inhibitor (8′). After the last cycle, 1x Spectral DAPI (Akoya Biosciences) was used as nuclear stain (5′).</p></section><section id="Sec8"><h3 class="pmc_sec_title">Classification of the metastasis subtypes MetA-C</h3>
<p id="Par14">For 119 of the metastasis cases, frozen tissue samples had been previously profiled by whole-genome transcriptomic analysis using either the human HT12 Illumina Beadchip technique (Illumina, San Diego, CA, USA) [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>] or the Clariom D Human Array technique (Thermo Fisher Scientific Inc., Life Technologies, Carlsbad, CA, USA [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par15">Here, data sets (<a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE29650" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE29650</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE101607" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE101607</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189343" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE189343</a>, <a href="https://www.ncbi.nlm.nih.gov/geo/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/geo/</a>) were merged and batch-corrected to enable combined analysis. The fraction (0.0<strong>–</strong>1.0) of each tissue sample with MetA-C characteristics was determined based on the expression levels of 157 pre-defined MetA-C-differentiating genes, as previously described [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Furthermore, samples were classified into MetA, MetB or MetC based on their dominant subtype [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p></section><section id="Sec9"><h3 class="pmc_sec_title">Statistics</h3>
<p id="Par16">Continuous variables were given as median (25th; 75th percentiles) and ordinal variables were given as number (percentage). Non-parametric statistics were used to compare groups and for correlation analyses (Kruskal-Wallis test with Dunn’s multiple comparison test and the Spearman rank correlation test). Morphological variables were dichotomized as positive/negative or based on quartiles in survival analysis. Cancer-specific survival was analyzed using the log-rank test with death from PC as event and other causes as censored events. Follow-up started at the date of ADT and ended at the date of death or the latest follow-up. All tests were two sided and <em>p</em>-values less than 0.05 were considered statistically significant. Statistical analysis was performed using the GraphPad Prism version 10, and SPSS version 28.</p></section></section><section id="Sec3"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec10"><h3 class="pmc_sec_title">Tumor epithelial markers</h3>
<section id="Sec11"><h4 class="pmc_sec_title">PSA and Ki67</h4>
<p id="Par17">PSA and proliferation (Ki67) immunostaining scores were measured as surrogate markers for the molecular MetA and MetB metastases subtypes and as markers linked to patient prognosis after ADT [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. In this metastasis cohort, the mean PSA staining score of tumor epithelial cells was 7 (median 6, Q1 4, Q4 10, range 1–12, <em>n</em> = 164) and the mean Ki67 + fraction was 20% (median 16, Q1 9, Q4 26, range 1–80, <em>n</em> = 162), indicating substantial variability between patients (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>). The transcriptomic MetA-C subtypes were evaluated in 119 cases, demonstrating mean MetA, B, and C fractions of 55, 24, and 21%, respectively (MetA: median 58, Q1 39, Q4 76, range 0-100, MetB: median 18, Q1 5, Q4 33, range 0-100, and MetC: median 15, Q1 3, Q4 29, range 0–95). Classified based on the dominant subtype of each sample, the cohort contained 80 MetA, 21 MetB, and 18 MetC patients. PSA and Ki67 scores were inversely correlated, with PSA significantly correlated to fraction of MetA and Ki67 to fraction of MetB (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). Patients with MetA-dominant metastases had significantly higher PSA score and lower Ki67 levels compared to patients with MetB-dominant metastases (Fig. <a href="#Fig1" class="usa-link">1</a>a). Consistent with prior findings, the MetB subtype, low PSA, high Ki67, and high Ki67/PSA ratio were associated with short survival after ADT (Fig. <a href="#Fig1" class="usa-link">1</a>b).</p>
<figure class="fig xbox font-sm" id="Fig1"><h5 class="obj_head">Fig. 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/bd283722db0f/10585_2025_10365_Fig1_HTML.jpg" loading="lazy" id="d33e830" height="454" width="677" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Tumor cell proliferation and PSA expression in relation to the molecular metastasis subtypes MetA-C and patient prognosis. <strong>a</strong> Graphs showing how tumor epithelial cell PSA and Ki67 staining scores differ between MetA, Met B and MetC dominating metastasis subtypes. * <em>p</em> &lt; 0.05, *** <em>p</em> &lt; 0.001, ns = not significantly different. <strong>b</strong> Kaplan-Meier curves showing survival after androgen-deprivation therapy (ADT) in relation to dominant molecular subtypes (MetA-C), tumor cell PSA, Ki67, and Ki67/PSA staining scores. <strong>c</strong> Sections from bone metastases, classified to contain different fractions of the MetA, MetB and MetC subtypes, double-stained for PSA and Ki67. Metastases with high MetA fractions (left) showed homogeneously strong PSA and low Ki67 staining, whereas metastases with high MetB fractions (middle) showed the opposite pattern. In metastases with a dominating MetA fraction but also containing a substantial MetB component (right), local areas with moderate to high PSA and low to moderate Ki67 (MetA-like pattern) and adjacent areas with low PSA and high Ki67 (MetB-like pattern) were seen, suggesting spatial heterogeneities in tumor cell phenotypes</p></figcaption></figure><p id="Par20">As most metastases consist of varying fractions of the MetA-C subtypes [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>], individual metastases may be heterogeneous and contain tumor cell clones with different molecular profiles. To further investigate spatial heterogeneity, we performed double staining for PSA and Ki67 in cases with known MetA-C subtype fractions.</p>
<p id="Par21">In cases with a high MetA fraction (Q4, MetA &gt; 75%), tumor cells showed strong, homogeneous PSA staining, with relatively few Ki67 + cells, primarily located at periphery of tumor cell nests, resembling the pattern seen in normal prostate glands (Fig. <a href="#Fig1" class="usa-link">1</a>c). In other cases, Ki67 + tumor cells were observed both in the central and peripheral parts of tumor cell nests (Fig. <a href="#Fig1" class="usa-link">1</a>c). Minor areas within the same metastasis sometimes showed high Ki67 and low PSA expression, suggesting focal development of more malignant clones within MetA-dominant tumors (Fig. <a href="#Fig1" class="usa-link">1</a>c).</p>
<p id="Par22">In cases with a high MetB fraction (Q4, MetB &gt; 33%), PSA staining was largely absent or low and scattered, while Ki67 + cells were abundant throughout the tumor (Fig. <a href="#Fig1" class="usa-link">1</a>c). In metastases with mixed MetA and MetB fractions, PSA and Ki67 labeling varied, suggesting that different areas were enriched for either MetA (high PSA/low Ki67) or MetB (low PSA/high Ki67) (Fig. <a href="#Fig1" class="usa-link">1</a>c) but areas with high Ki67 and high PSA could also be observed. The size of these areas varied between cases, where some areas were rather small (evident only at high magnification) whereas others were considerably larger (evident at low magnification) (Fig. <a href="#Fig1" class="usa-link">1</a>c).</p>
<p id="Par23">Overall, this suggests inter-patient and intra-patient variability in epithelial cell phenotypes.</p></section><section id="Sec17"><h4 class="pmc_sec_title">Androgen receptor (AR), chromogranin A (CHRA), apoptosis and tumor ERG</h4>
<p id="Par24">The mean AR staining score in tumor epithelial cells was 8, but with large variability observed (median 8, Q1 4, Q4 12, range 0–12, <em>n</em> = 156) (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>). The neuroendocrine marker CHRA was undetectable in 94 of 139 samples with a mean CHRA + cell density of 2% (median 0, Q1 0, Q4 0.2, range 0–80%, <em>n</em> = 139) (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>). In cases with CHRA + tumor cells, positive cells were generally isolated, located next to unstained cells (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>). Tumor cell apoptosis was generally low with a mean apoptotic tumor cell density of 1% (median 0.5, Q1 0.3, Q4 1.0, range 0–23%, <em>n</em> = 78) (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>). Metastatic tumor cells were ERG + in 26% of the cases (36 of 139), suggesting TMPRSS2-ERG fusion gene expression [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>] (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>).</p>
<p id="Par25">The tumor cell AR score, CHRA levels, apoptosis levels, or ERG score were not associated with outcome, and did not differ between patients with different metastasis subtypes (MetA-C), except for CHRA that was significantly lower in MetC compared to MetB patients (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a>).</p></section></section><section id="Sec456"><h3 class="pmc_sec_title">Tumor stroma markers</h3>
<section id="Sec12"><h4 class="pmc_sec_title">Markers of blood vessels and fibroblast-like cells</h4>
<p id="Par26">Staining of smooth muscle actin (SMA), platelet derived growth factor β (PDGFRB), stroma derived factor 1 (SDF1), periostin (POSTN), and ERG was observed in blood vessels within both normal bone marrow and bone metastases (Fig. <a href="#Fig2" class="usa-link">2</a>a). SMA, PDGFRB and POSTN were detected in pericytes and vascular smooth muscle cells in both large and small vessels, endothelial cells stained positive for SDF1, POSTN, and ERG (Fig. <a href="#Fig2" class="usa-link">2</a>a). In some cases, SMA and PDGFRB staining was focal, localized to the mural layer of small blood vessels penetrating tumor nests (Fig. <a href="#Fig2" class="usa-link">2</a>a).</p>
<figure class="fig xbox font-sm" id="Fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/109a830dcf56/10585_2025_10365_Fig2_HTML.jpg" loading="lazy" id="d33e872" height="767" width="677" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Stroma cell heterogeneities in relation to the molecular metastasis subtypes MetA-C and patient prognosis. Immunohistochemical localization of factors expressed in <strong>a</strong> blood vessel walls and <strong>b</strong> fibroblast-like cells. <strong>c</strong> Double staining of ERG (localized in endothelial cell nuclei) and various stroma cell markers. All markers except DCN were localized adjacent to endothelial cells. <strong>d</strong> Double staining of DCN + SMA, and DCN + PDGFRB. SMA was expressed mainly in blood vessel walls adjacent to tumor epithelial cells whereas DCN was expressed in the broad stroma septa. PBGDRB was expressed adjacent to DCN in broad stroma septa and in blood vessels adjacent to tumor cells. <strong>e</strong> Multiplex staining showing that most stroma cell markers were expressed in the broad stroma septa whereas SMA, SDF-1 and focal PDGFRB were also detected in and around the tiny blood vessels penetrating tumor cell nests. <strong>f</strong> Kaplan-Meier analysis showing that survival after androgen-deprivation therapy (ADT) was related to the density of ERG + endothelial cells and to the stroma densities of POSTN and DCN. <strong>g</strong> Boxplots showing densities of stroma SMA, ERG, SDF-1, DCN, PDGFRB, and POSTN in relation to dominating metastasis subtypes MetA-C. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ns = not significantly different</p></figcaption></figure><p id="Par27">SMA, PDGFRB, SDF1, POSTN, and DCN were also found in fibroblast-like cells within the connective tissue septa separating tumor cell nests (Fig. <a href="#Fig2" class="usa-link">2</a>b), with POSTN and DCN occasionally present at the bone surface (data not shown). Additionally, tumor cells stained positive for SDF1 in some patients (data not shown).</p>
<p id="Par28">The mean densities of SMA + cells and SDF1 + stroma were 5% of the metastasis volume (SMA: median 5, Q1 3.1, Q4 6.9, range 0.7–13.0, <em>n</em> = 108; SDF1: median 5, Q1 3.5, Q4 6.8, range 0.4–13.0, <em>n</em> = 117), while PDGFRB + stromal cells had approximately double the density, in mean constituting 10% of the metastasis volume (median 10, Q1 6.6, Q4 13, range = 1.2–22.0, <em>n</em> = 91). POSTN + and DCN + cells comprised about 3% each of the metastasis volume (POSTN: median 2.3, Q1 0.82, Q4 3.6, range 0–16, <em>n</em> = 80; DCN: median 1.8, Q1 0.83, range 0–14, Q4 4.5, <em>n</em> = 84), while ERG + endothelial cells had a mean density of 1% (median 1.0, Q1 0.66, Q4 1.5, range 0.2–3.6, <em>n</em> = 127).</p>
<p id="Par29">To investigate stromal cell types adjacent to endothelial cells, double staining for ERG and the other stromal markers was performed. ERG + nuclei were frequently found close to SDF1 + endothelial cells, particularly in the smallest blood vessels near tumor cell nests (Fig. <a href="#Fig2" class="usa-link">2</a>c). ERG + cells were also found adjacent to SMA+, PDGFRB+, and POSTN + mural vascular cells (Fig. <a href="#Fig2" class="usa-link">2</a>c). However, ERG + nuclei were rarely found near DCN + cells and extracellular matrix. DCN was instead located closer to PDGFRB + or SMA + cells within the broader connective tissue septa (Fig. <a href="#Fig2" class="usa-link">2</a>d). Notably, DCN + cells were generally absent from the small PDGFRB+/SMA + vessels within the tumor cell nests (Fig. <a href="#Fig2" class="usa-link">2</a>d). Multiplex staining confirmed that SMA, PDGFRB, SDF1, and DCN were highly expressed in the broader connective tissue septa (Fig. <a href="#Fig2" class="usa-link">2</a>e). Within the tumor, SDF-1, SMA, and focal PDGFRB were observed in the thinner stroma strands and micro-vessels (Fig. <a href="#Fig2" class="usa-link">2</a>e). The highest number of tumor cells in direct contact with stroma was found along these thin stroma septa and micro-vessels.</p>
<p id="Par30">The densities of SMA+, PDGFRB+, or SDF1 + cells were not significantly related to ADT outcomes (Supplement Fig. <a href="#MOESM1" class="usa-link">3</a>). However, higher densities of ERG + endothelial cells or high POSTN levels were significantly associated with poor ADT outcomes (Fig. <a href="#Fig2" class="usa-link">2</a>f). In contrast, high DCN levels were significantly associated with better prognosis (Fig. <a href="#Fig2" class="usa-link">2</a>f).</p>
<p id="Par32">SMA + and ERG + stromal cell densities were significantly higher in MetB metastases compared to MetA, while SDF1 + and DCN + cells were significantly lower in MetB metastases (Fig. <a href="#Fig2" class="usa-link">2</a>g). No differences were observed in PDGFRB or POSTN densities between metastatic subtypes (Fig. <a href="#Fig2" class="usa-link">2</a>g). Higher MetA fraction correlated positively with SDF1 and DCN, and inversely with SMA, while higher MetB fraction correlated positively with SMA and inversely with SDF1 and DCN (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). The MetC fraction did not correlate with any blood vessel or fibroblast markers examined (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). Similarly, PSA score correlated with SDF1 and DCN, and inversely with ERG + endothelium, while tumor Ki67 correlated with SMA and ERG + endothelium (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>).</p>
<p id="Par33">In summary, this suggests that “PSA-high/MetA-enriched” metastases are characterized by lower vascular density and a stroma with higher SDF1 and DCN levels, whereas “Ki67-high/MetB-enriched” metastases have a stroma with higher vascular density and higher SMA levels.</p></section><section id="Sec13"><h4 class="pmc_sec_title">Stroma Ki67</h4>
<p id="Par34">To assess reactive stroma, we examined Ki67 expression in stromal cells. The mean fraction of Ki67 + stromal cells was 5% (median 4, Q1 3, Q4 7, range 0.5–20.0, <em>n</em> = 127). Ki67 labeling was predominantly observed in endothelial and mural vascular cells (Fig. <a href="#Fig3" class="usa-link">3</a>a), suggesting that it mainly reflects vascular proliferation.</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/9b28af7e4a99/10585_2025_10365_Fig3_HTML.jpg" loading="lazy" id="d33e1047" height="271" width="676" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Stroma cell proliferation and androgen receptor expression in relation to the molecular metastasis subtypes MetA-C and patient prognosis. Ki67 (<strong>a</strong>) and AR (<strong>c</strong>) stained sections showing positive immunostaining not only in tumor cells, but also in stroma cells, particularly in blood vessels (arrows). Boxplots showing the lowest density of Ki67 positive stroma cells in MetA (<strong>b</strong>) and the lowest density of AR positive stroma cells in MetB dominated metastases (<strong>e</strong>). Kaplan-Meier analysis showing that survival after androgen-deprivation therapy (ADT) was related to the density of AR + stromal cells (<strong>d</strong>). *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ns = not significantly different</p></figcaption></figure><p id="Par35">The density of Ki67 + stromal cells was not linked to prognosis after ADT (Supplement Fig. <a href="#MOESM1" class="usa-link">3</a>) but was significantly higher in MetB compared to MetA metastases (Fig. <a href="#Fig3" class="usa-link">3</a>b). Accordingly, the MetA fraction and PSA score were inversely correlated with stromal Ki67, whereas MetB fraction and tumor Ki67 positively correlated with stromal Ki67 (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). This indicates that Ki67-high/MetB-enriched metastases have a more reactive stroma with increased vascular proliferation.</p></section><section id="Sec15"><h4 class="pmc_sec_title">Stroma androgen receptors</h4>
<p id="Par36">As previously seen, AR staining was prominent in the nuclei of metastatic tumor epithelial cells, while most stromal cells were AR-negative [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>] (Supplement Fig. <a href="#MOESM1" class="usa-link">1</a> and Fig. <a href="#MOESM1" class="usa-link">3</a>c). However, low to moderate AR staining was observed in a few osteoblasts, blood vessels, and subsets of inflammatory cells (Fig. <a href="#Fig3" class="usa-link">3</a>c), consistent with earlier reports [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Only 3% of stromal cells were AR-positive (median 2.7, Q1 1.5, Q4 4, range 0.3–15.0, <em>n</em> = 113), demonstrating a major difference from that in primary tumors where stroma cells are mainly AR+ [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par37">Survival analysis showed that patients with very low AR + stroma cell density had the shortest survival after ADT (Fig. <a href="#Fig3" class="usa-link">3</a>d). MetA metastases had significantly higher stromal AR levels than MetB metastases (Fig. <a href="#Fig3" class="usa-link">3</a>e), and AR + stromal cells correlated with MetA fraction and inversely with MetB fraction (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). Similarly, stromal AR correlated with PSA score and inversely with tumor Ki67 (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>), suggesting that PSA-high/MetA-enriched metastases have a more androgen-responsive stroma compared to Ki67-high/MetB-enriched metastases.</p></section><section id="Sec14"><h4 class="pmc_sec_title">Macrophages and T-lymphocytes</h4>
<p id="Par38">To assess immune cell density, we stained the metastases for the pan-macrophage marker CD68 and the T-lymphocyte marker CD3 (Fig. <a href="#Fig4" class="usa-link">4</a>a). The mean density of CD68 + macrophages was 4% of the metastasis volume (median 2.6, Q1 1.2, Q4 5.0, range 0–21, <em>n</em> = 144), while the mean density of CD3 + T-lymphocytes was 0.4% (median 0.25, Q1 0.10, Q4 0.50, range 0-4.3, <em>n</em> = 102). Neither macrophage nor T-lymphocyte densities were associated with survival after ADT (Supplement Fig. <a href="#MOESM1" class="usa-link">3</a>).</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/57d1dae44369/10585_2025_10365_Fig4_HTML.jpg" loading="lazy" id="d33e1169" height="156" width="677" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immune cell infiltration in bone metastases of different molecular subtypes. <strong>a</strong> Sections immunostained for CD68 (macrophages) and CD3 (T-lymphocytes). <strong>b-c)</strong> Boxplots showing densities of CD68, CD3, and bone in relation to dominating metastasis molecular subtypes MetA-C *<em>p</em> &lt; 0.05, ns = not significantly different</p></figcaption></figure><p id="Par40">There was no difference in CD68 + cell levels among the MetA-C subtypes, but MetC metastases had significantly higher CD3 + cell levels compared to MetA (Fig. <a href="#Fig4" class="usa-link">4</a>b). CD68 showed no association with metastatic subtypes or with PSA or tumor Ki67 but correlated with PDGFRB and CD3 (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>). CD3 also inversely correlated with MetA and bone density, but showed no associations with the other subtypes, PSA, or tumor Ki67 (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>).</p></section><section id="Sec18"><h4 class="pmc_sec_title">Bone</h4>
<p id="Par42">The mean bone density within the metastases was 13%, but varied widely between patients, ranging from 0 to 50% of the metastasis volume (median 11, Q1 5.4, Q4 18, <em>n</em> = 140). Interestingly, some “bone metastases” contained very little bone. Bone density was not linked to metastatic subtypes (Fig. <a href="#Fig4" class="usa-link">4</a>c) or to ADT outcomes (Supplement Fig. <a href="#Fig3" class="usa-link">3</a>). While bone density did not correlate with the MetA-C fractions, it was positively correlated with PSA score and inversely with tumor Ki67 (Supplement Fig. <a href="#MOESM1" class="usa-link">2</a>), indicating that PSA-high/Ki67 low metastases tend to contain more bone.</p></section></section><section id="Sec789"><h3 class="pmc_sec_title">Morphological stroma subtypes</h3>
<p id="Par43">We also analyzed the general morphology of the bone metastases and identified three distinct stroma subtypes: type 1 (<em>n</em> = 36), type 2 (<em>n</em> = 26) and mixed type (<em>n</em> = 96) metastases. The type 1 metastases had nests of tumor epithelial cells growing in spaces separated by bone tissue, and by thin strands of stroma containing small blood vessels (Fig. <a href="#Fig5" class="usa-link">5</a>a). The tumor cells were closely associated with each other, bone surfaces, and remaining bone marrow components, but contained few fibroblast-like cells and no smooth muscle cells. In contrast, the type 2 metastases contained little bone or bone marrow, with tumor cells growing in a vascularized stroma composed of fibroblast-like cells, extracellular matrix, and some inflammatory cells (Fig. <a href="#Fig5" class="usa-link">5</a>a). The stroma formed septa that separated tumor cell nests, varying in thickness and vascularity. Tumor cells were not directly in contact with bone or hematopoietic cells but were closely associated with other tumor cells, endothelial cells, pericytes, and fibroblast-like cells. The largest group of mixed type metastases exhibited type 1 and type 2 areas in different parts of the same metastasis, indicating that spatial heterogeneity is very common and perhaps underestimated due to insufficient sampling from all parts of a metastasis.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/23a1c9bee8d3/10585_2025_10365_Fig5_HTML.jpg" loading="lazy" id="d33e1254" height="836" width="677" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Characteristics of two distinct stoma subtypes in bone metastases from prostate cancer. <strong>a</strong> Htx-eosin-stained sections representing stroma subtype 1 (tumor cells growing in stroma spaces separated by bone-tissue), and stroma subtype 2 (tumor cells growing in a prominent connective tissue stroma). Boxplots showing <strong>b</strong> Ki67 and PSA staining, <strong>c</strong> metastasis fractions of cells with MetA-C characteristics, and <strong>d</strong> densities of ERG, POSTN, SMA, and bone in relation to metastases stroma subtypes (type1, type 2 or mixed type1-type2). *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ns = not significantly different. <strong>e</strong> Kaplan-Meier analysis showing that stroma subtypes are related to survival after androgen-deprivation therapy (ADT). <strong>f</strong> Section of a micro-metastasis double stained for PSA + Ki67, showing tumor epithelial cells forming gland like, PSA positive structures growing in the bone marrow within a stroma subtype type 1</p></figcaption></figure><p id="Par45">Type 2 metastases had significantly higher tumor cell proliferation and lower PSA score compared to type 1 and mixed metastases (Fig. <a href="#Fig5" class="usa-link">5</a>b), but the fractions of MetA-C were not related to stroma subtype (Fig. <a href="#Fig5" class="usa-link">5</a>c). Among the stroma factors, ERG + endothelial cells, POSTN levels, and SMA levels were higher in type 2 metastases, while bone density was lower (Fig. <a href="#Fig5" class="usa-link">5</a>d). Type 1 metastases were significantly associated with better prognosis after ADT compared to mixed and type 2 metastases (Fig. <a href="#Fig5" class="usa-link">5</a>e).</p>
<p id="Par46">In some patients with adjacent vertebral tissue sampled, we identified micro-metastases consisting of small tumor cell clusters located on bone surfaces or within normal bone marrow near blood vessels and hematopoietic cells, classifying as type 1 metastases (Fig. <a href="#Fig5" class="usa-link">5</a>f). In this study we did not quantify epithelial and stroma markers in micro-metastases further.</p>
<p id="Par47">We then compared the morphology of metastases from operated cases (spine and hip) and from biopsy samples (crista and rib). Among the factors measured, we found that the density of CD68 + macrophages was significantly higher in the operated cases in comparison to biopsied cases (4.1 ± 3.9% vs. 0.64 ± 0.66%, <em>n</em> = 132 and <em>n</em> = 12, respectively, <em>p</em> &lt; 0.001). Moreover, Ki67 + cells in the stroma and MetC fraction were significantly higher in spine and hip compared to crista (Ki67 stroma: 5.6 ± 4.2% vs. 2.9 ± 1.4%, <em>n</em> = 118 and <em>n</em> = 9, respectively, <em>p</em> = 0.019, MetC: 0.23 ± 0.22 vs. 0.14 ± 0.19, <em>n</em> = 111 and <em>n</em> = 20, <em>p</em> = 0.021).</p>
<p id="Par48">In summary, metastases with type 1 stroma were associated with higher bone content, lower tumor cell Ki67 levels, higher PSA scores and slightly better prognosis. In contrast, metastases with type 2 stroma contained less bone and had more ERG + blood vessels and POSTN + cells, exhibiting higher tumor proliferation and lower PSA levels.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Epithelial and stromal factors in relation to treatment</h3>
<p id="Par49">In this study we had access to metastases from 30 hormone-naïve, 16 short-term ADT, and 121 CRPC patients. We found that the MetA fraction was lower in CRPC compared to hormone-naïve metastases, while the MetB fraction was higher in CRPC relative to the other cases (Fig. <a href="#Fig6" class="usa-link">6</a>a). There were no significant changes in PSA score or Ki67 levels among hormone-naïve, short-term treated, or CRPC patients; however, short-term treatment appeared to lower tumor epithelial AR levels and to increase apoptosis (Fig. <a href="#Fig6" class="usa-link">6</a>b). Also, apoptosis was slightly higher in CRPC compared to hormone-naive cases (Fig. <a href="#Fig6" class="usa-link">6</a>b).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370827_10585_2025_10365_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca9/12370827/54dc0a539abd/10585_2025_10365_Fig6_HTML.jpg" loading="lazy" id="d33e1344" height="862" width="750" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Molecular metastasis subtypes and cellular markers in relation to hormone therapy. Boxplots showing metastasis fractions of cells with MetA-C (<strong>a</strong>), PSA score, Ki67, AR tumor score, and apoptosis (<strong>b</strong>), and densities of POSTN, PDGFRB, and DCN (<strong>c</strong>) in patients with hormone-naïve (HN), short-term androgen-deprivation therapy (ST), and castration resistant prostate cancer (CRPC). *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ns = not significantly different</p></figcaption></figure><p id="Par51">Among the stromal factors examined, POSTN and PDGFRB were significantly higher in metastases from short-term ADT patients compared to hormone-naïve patients, while DCN levels were significantly lower in CRPC patients compared to those receiving short-term treatment (Fig. <a href="#Fig6" class="usa-link">6</a>c).</p>
<p id="Par52">In addition to ADT, some patients had received therapies for CRPC (Table <a href="#Tab1" class="usa-link">1</a>). In this cohort, bicalutamide treatment was associated with longer survival, while 2nd and 3rd line therapies and/or palliative radiation therapy towards the operated vertebra showed non-significant tendencies to increase survival (Supplementary Fig. <a href="#MOESM1" class="usa-link">4</a>). Metastases that had been radiated showed higher bone density and stroma AR staining than the rest, and previous bicalutamide treatment was associated with higher epithelial AR and stroma SMA staining (Supplement Fig. <a href="#MOESM1" class="usa-link">4</a>). Chemotherapy showed no obvious relation to any of the morphological markers examined (Supplement Fig. <a href="#MOESM1" class="usa-link">4</a>). For abiraterone and other second or third-line therapies for CRPC the number of men treated was too low for morphological comparisons (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<p id="Par53">In summary, short-term effects of ADT were observed on tumor cell nuclear AR levels and apoptosis, as well as on stromal POSTN and PDGFRB levels. CRPC metastases had higher tumor cell apoptosis compared to untreated patients and were enriched for the MetB subtype. Moreover, bicalutamide treatment for CRPC affected epithelial AR and stroma SMA levels.</p></section></section><section id="Sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par54">PC bone metastases can be divided into different subgroups, based on morphological and/or molecular diversities [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. In this study, we extend these observations by investigating morphological heterogeneities within individual metastases and between patients and examining how these variations relate to molecular tumor characteristics and patient prognosis after ADT.</p>
<p id="Par55">As earlier reported [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], and now confirmed in a larger cohort, we show that metastases with high proliferation and poor differentiation (Ki67 high, PSA low, MetB-enriched) are related to a particularly bad outcome after ADT. These metastases have low bone density (stroma subtype 2), high endothelial cell density, high stroma proliferation, high density of SMA, but low stroma AR density, and low densities of DCN and SDF-1. In contrast, metastases with lower proliferation, higher differentiation, and better outcome after ADT (Ki67 low, PSA high, MetA-enriched), often grow in more normal bone structures (stroma subtype 1). These cases also have higher stroma levels of AR, DCN, SDF-1, and lower endothelial cell density.</p>
<p id="Par56">As previously demonstrated, cell differentiation and growth in normal prostate and primary prostate tumors are influenced by bidirectional communication between epithelial cells and the surrounding stroma [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Here, markers like Ki67 and PSA in metastatic tumor cells could be linked to cellular diversities in the metastatic stroma suggesting that stroma cells play an important role in controlling tumor cell proliferation and differentiation also in metastases. The response to ADT in primary tumors is, in addition to direct effects on epithelial cells, also dependent on effects in AR + stroma cells [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>], with loss of AR + smooth muscle cells in the prostate stroma being linked to a weak ADT response in patients [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. In line with this, we here found that lower AR levels in metastatic stroma were associated with poorer outcomes after ADT. Notably, AR levels were higher in Ki67-low/PSA-high/MetA metastases compared to Ki67-high/PSA-low/MetB metastases, suggesting that stroma androgen responses differ between these subtypes.</p>
<p id="Par57">Short-term hormonal treatment appeared to reduce tumor cell AR staining and increase tumor cell apoptosis in bone metastases, while leaving cell proliferation (Ki67) and PSA expression unaffected. This contrasts with primary tumor tissue, where reduced AR staining is accompanied with a clear reduction in tumor cell proliferation and moderately increased apoptosis during the first weeks after surgical castration [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Thus, it is likely that the bone-environment acts to reduce the acute effects of ADT on tumor cells (see also [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]). As demonstrated in an experimental rat model for PC bone metastases, high IGF-1 levels within the bone environment may counteract effects of castration in PC metastases and, furthermore, IGF receptor inhibition could possibly be used to strengthen the ADT response in bone metastases [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>].</p>
<p id="Par58">When PC cells reach the bone marrow, they first colonize the hematopoietic stem cell niche at the bone surface and around blood vessels [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. At this early metastasis stage, the tumor microenvironment includes various cell types like osteoblasts, osteoclasts, endothelial cells, pericytes, adipocytes and inflammatory cells [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Accordingly, we noted this type of microenvironment in micro-metastases and in areas of metastases with a bone-rich stroma type 1. Presumably, as the metastasis grows, tumor cells fill up the bone marrow spaces and replace the bone and bone marrow, finally spreading outside the bone. Some metastases in our study (primarily those with low Ki67/high PSA/MetA) seemed to retain or form new bone structures (stroma type 1), while in others (mainly in those with high Ki67/low PSA/MetB) the bone and bone marrow were replaced by a more connective tissue-like microenvironment (stroma type 2). In line with this, patients with stroma type 1 had slightly better outcome after ADT. As most, and perhaps all, contained both type 1 and type 2 areas treatment responses probably vary between different parts of the same metastasis.</p>
<p id="Par59">Most studies on how the bone metastasis microenvironment influences PC dormancy and metastasis growth have been performed in vitro or in animal models and mainly focused on how tumor cells interact with bone cells like osteoblasts and osteoclasts and stem cell-niches [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>–<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. In line with this, bone metastases are commonly classified as osteoblastic, osteolytic or mixed [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>], stressing the importance of bone cells in metastasis biology. However, our findings, in line with Roudier et al. [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>], indicate that in advanced clinical bone metastases, the presence of bone and bone marrow is limited and, thus, few cancer cells are located near bone surfaces. This could explain why therapies targeting bone-tumor interactions in advanced patients have limited success [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Consequently, the vicious cycle between bone cells and PC cells [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>] likely plays a larger role during bone metastasis establishment than in later phases. In clinically established metastases, we showed that most tumor cells were clustered around small blood vessels (ERG+, SDF1+, POSTN+, SMA+, PDGFRB+), suggesting that other cell interactions, especially involving blood vessels, might drive later stages of metastasis growth.</p>
<p id="Par60">Consistent with this, the density of endothelial cell ERG + nuclei was positively correlated with cell proliferation and negatively correlated with cellular PSA levels, and higher blood vessel density was associated with a poorer outcome after ADT. The proximity of blood vessels to tumor epithelial cells suggests a possible role for angiocrine signaling or angiogenesis in regulating metastasis growth and treatment responses [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. For instance, endothelial cells can protect metastatic cancer cells from cytotoxic drugs [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Moreover, in normal prostate tissue, castration-induced gland involution is preceded by vascular involution and a significant drop in blood flow, and testosterone-induced glandular regrowth follows VEGF-mediated vascular growth in castrated animals [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>, <a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. In the current study, however, ADT did not affect endothelial cell density in bone metastases. The importance of blood vessels in the response to ADT in PC bone metastases remains unclear.</p>
<p id="Par61">Many studies in primary tumors have focused on the various stimulatory and inhibitory effects of different types of cancer-associated fibroblasts (CAFs) [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>–<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. While CAFs are prevalent in primary prostate tumors, they are less abundant but not absent in bone metastases [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. In this study, we identified fibroblast-like cells, particularly in metastases with a type 2 stroma. Baryawno et al. [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>] demonstrated that bone metastases can contain up to 17 different non-bone stromal cell types. Together with the findings from our study, which also shows the importance of various non-bone stromal cells, this highlights the need for further research to better understand their roles and impact.</p>
<p id="Par62">Factors like SDF-1, POSTN, SMA and PDGFRB were found both in blood vessels and in fibroblast-like cells. SDF1 (also known as CXCL12) binds to receptors on PC cells and thereby plays a role in tumor-cell homing to the bone marrow [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Additionally, SDF-1 is involved in inducing metastasis dormancy [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. Our findings showed high SDF-1 levels in MetA cases, compared to the other metastatic subtypes. POSTN, located in blood vessels and fibroblast-like cells, was higher in metastases with a mixed or type 2 stroma and the only stromal factor examined here that was coupled to a worse prognosis without being related to the Ki67 high/PSA low/MetB subtype. In the normal prostate, POSTN is primarily expressed in the stroma, particularly in endothelial cells, and increased expression in primary tumors is related to enhanced aggressiveness [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Endothelial cells in newly formed blood vessels within tumors release POSTN, which promote the outgrowth of bone metastases in experimental models [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Additional studies are needed to clarify the specific role of POSTN in PC bone metastasis. PDGFRB staining in the stroma did not correlate with outcomes or metastasis molecular subtypes, but we cannot exclude the possibility that spatial differences, i.e. expression in blood vessels penetrating tumor cell nests, could give different effects than PDGFRB positive cells more remote from tumor epithelial cells.</p>
<p id="Par63">DCN expression was mainly found in fibroblast-like cells and in the matrix in the bone metastasis stroma and the current study suggests that reduced synthesis of DCN may contribute to the growth of the most aggressive bone metastases (Ki67 high, PSA low, MetB). In line with this, lower DCN levels were associated with a worse outcome. DCN plays a crucial regulatory role in normal prostate tissue and primary PC. It is typically expressed in fibroblast-like cells adjacent to prostate glands but is down-regulated in higher-grade tumors [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>, <a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. DCN is also expressed in osteoblasts and in all five fibroblast-like cell types present in normal bone marrow [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. It promotes epithelial cell differentiation and inhibits proliferation [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>], and in line with this correlated with tumor PSA levels in the metastases. Additionally, DCN inhibits several key receptors involved in prostate cell functions, such as AR, EGFR, TGFBR, IGFR, MET and PDGFR [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. DCN also suppresses angiogenesis, tumor growth, and bone metastasis in PC models [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>–<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. In this study, DCN was found to be absent to low in the small stromal septa near tumor cell nests, especially in MetB cases. Given its potential therapeutic role [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>] testing DCN as a novel treatment for MetB could be of interest. Hypothetically, the combination of low SDF-1 and DCN levels, along with elevated local PDGFRB expression, may induce changes in both the vasculature and non-vascular components of the stroma, leading to a more aggressive bone metastasis phenotype.</p>
<p id="Par64">The growth of PC cells in the bone marrow leads to an altered immune microenvironment [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>] and various immune cell types may also affect how PC cells respond to ADT [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>–<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. In our study, quantification of CD68 + macrophages and CD3 + lymphocytes did not reveal any clear association between the level of immune cell infiltration and treatment response. Also, we observed no differences in immune cell infiltration between metastases of different molecular subtypes. However, the possibility that tumor infiltration of different monocyte and T cell lineages may be involved in regulating tumor response to ADT as well as to other therapies, including immunotherapy, needs to be further investigated.</p>
<p id="Par65">Importantly, most tumor epithelial cells in the clinically manifested bone metastases were not located next to stroma cells, rather, they were located close to other tumor epithelial cells, exhibiting variations in epithelial cell phenotypes. Molecular subtype analysis suggests that most metastases contain a mix of cells with MetA-C characteristics [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. IHC markers related to MetA and B subtypes (PSA and Ki67) had significant intra-metastasis heterogeneity. Furthermore, heterogeneities were also found for stroma subtype 1 and 2, suggesting also stromal heterogeneity in metastases, similar to what has been previously described for primary PC [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>, <a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>, <a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>–<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. This suggests that many metastases contain mixtures of tumor cell subclones with different phenotypic characteristics, furthermore, being in contact with local variations in the microenvironment. If interactions among different subclones of tumor epithelial cells affect metastasis behavior and treatment responses, and if treatment effects vary within different regions of the same metastasis, and between different metastases, this needs to be considered when designing optimal treatment protocols.</p>
<p id="Par66">In summary, the current study verifies that high tumor cell proliferation and low PSA expression in PC bone metastases are clearly related to an aggressive molecular subtype (MetB) and poor patient prognosis after ADT. The study also demonstrates the relationship between this aggressive metastasis phenotype and morphological characteristics of the bone microenvironment (high endothelial density, high POSTN and SMA expression as well as low DCN expression). Importantly, our observations suggest that PC bone metastases, like primary prostate tumors and other tumor types [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>], show high inter and intra metastatic heterogeneity, harboring different tumor subclones interacting with each other and with various stromal cells, like endothelial cells, pericytes and fibroblasts. The role of those stroma cells, particularly of those in the blood vessel walls, remains unclear and needs to be examined in more detail in relation to clonal response and treatment resistance, for example by using single-cell and spatial transcriptomics on human metastasis samples. Such studies could uncover critical insights into metastasis stroma heterogeneities and their importance for growth and treatment responses in different metastasis molecular subgroups and in different parts of a single metastasis.</p></section><section id="Sec5"><h2 class="pmc_sec_title">Electronic supplementary material</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12370827/bin/10585_2025_10365_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (1MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors are grateful to all the patients who participated in the study. This research was funded by the Swedish Cancer Society (22-2041 and 24-3732), the Swedish Research Council (2022-00946), Sjöbergstiftelsen (2020-12-15), and the Cancer Research Foundation in Northern Sweden (AMP 24-1156 and LP 21-2273).</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization and design, A.B., P.W., and S.H.B., clinical data acquisition, J.W., S.C., A.W., C.T.K., K.W., and A.J., data analysis and methodology, A.B., P.W., S.H.B., J.S., A.N., E.T., P.A., S.G., and M.L., interpretation of data, and statistical analysis; A.B, P.W., and S.H.B. All authors have reviewed, edited and agreed to the final version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open access funding provided by Umea University.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Conflict of interest</h3>
<p id="Par67">A.B., E.T., and P.W. have a pending patent application related to the metastasis subtypes MetA-C and to Ki67 and PSA immunostaining as surrogate markers for the molecular metastasis subtypes (‘Methods for diagnosis and prognosis of prostate cancer’, EP2020/054681).</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>Pernilla Wikström, Anders Bergh: Shared senior authorship.</p></div>
<div class="fn p" id="fn2">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Cornford P et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate Cancer. Eur Urol 79(2):263–282
</cite> [<a href="https://doi.org/10.1016/j.eururo.2020.09.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33039206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cornford%20P%20et%20al%20(2021)%20EAU-EANM-ESTRO-ESUR-SIOG%20guidelines%20on%20prostate%20cancer.%20Part%20II-2020%20update:%20treatment%20of%20relapsing%20and%20metastatic%20prostate%20Cancer.%20Eur%20Urol%2079(2):263%E2%80%93282" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Bergstrom SH, Rudolfsson SH, Bergh A (2016) Rat prostate tumor cells progress in the bone microenvironment to a highly aggressive phenotype. Neoplasia 18(3):152–161
</cite> [<a href="https://doi.org/10.1016/j.neo.2016.01.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4796808/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26992916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bergstrom%20SH,%20Rudolfsson%20SH,%20Bergh%20A%20(2016)%20Rat%20prostate%20tumor%20cells%20progress%20in%20the%20bone%20microenvironment%20to%20a%20highly%20aggressive%20phenotype.%20Neoplasia%2018(3):152%E2%80%93161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Crnalic S et al (2010) Nuclear androgen receptor staining in bone metastases is related to a poor outcome in prostate cancer patients. Endocr-Relat Cancer 17(4):885–895
</cite> [<a href="https://doi.org/10.1677/ERC-10-0059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20688881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crnalic%20S%20et%20al%20(2010)%20Nuclear%20androgen%20receptor%20staining%20in%20bone%20metastases%20is%20related%20to%20a%20poor%20outcome%20in%20prostate%20cancer%20patients.%20Endocr-Relat%20Cancer%2017(4):885%E2%80%93895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ohlson N et al (2005) Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment. Prostate 62(4):307–315
</cite> [<a href="https://doi.org/10.1002/pros.20139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15389788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ohlson%20N%20et%20al%20(2005)%20Cell%20proliferation%20and%20apoptosis%20in%20prostate%20tumors%20and%20adjacent%20non-malignant%20prostate%20tissue%20in%20patients%20at%20different%20time-points%20after%20castration%20treatment.%20Prostate%2062(4):307%E2%80%93315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Iglesias-Gato D et al (2018) The proteome of prostate cancer bone metastasis reveals heterogeneity with prognostic implications. Clin Cancer Res 24(21):5433–5444
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-18-1229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30042207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iglesias-Gato%20D%20et%20al%20(2018)%20The%20proteome%20of%20prostate%20cancer%20bone%20metastasis%20reveals%20heterogeneity%20with%20prognostic%20implications.%20Clin%20Cancer%20Res%2024(21):5433%E2%80%935444" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Thysell E et al (2022) Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C. Mol Oncol 16(4):846–859
</cite> [<a href="https://doi.org/10.1002/1878-0261.13158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8847984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34889043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thysell%20E%20et%20al%20(2022)%20Clinical%20and%20biological%20relevance%20of%20the%20transcriptomic-based%20prostate%20cancer%20metastasis%20subtypes%20MetA-C.%20Mol%20Oncol%2016(4):846%E2%80%93859" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Thysell E et al (2019) Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor. Mol Oncol 13(8):1763–1777
</cite> [<a href="https://doi.org/10.1002/1878-0261.12526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6670017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31162796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thysell%20E%20et%20al%20(2019)%20Gene%20expression%20profiles%20define%20molecular%20subtypes%20of%20prostate%20cancer%20bone%20metastases%20with%20different%20outcomes%20and%20morphology%20traceable%20back%20to%20the%20primary%20tumor.%20Mol%20Oncol%2013(8):1763%E2%80%931777" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Wikstrom P et al (2022) Epithelial and stromal characteristics of primary tumors predict the bone metastatic subtype of prostate Cancer and patient survival after Androgen-Deprivation therapy. Cancers (Basel) 1421</cite> [<a href="https://doi.org/10.3390/cancers14215195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9659192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36358614/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Abida W et al (2019) Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA 116(23):11428–11436
</cite> [<a href="https://doi.org/10.1073/pnas.1902651116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6561293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31061129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abida%20W%20et%20al%20(2019)%20Genomic%20correlates%20of%20clinical%20outcome%20in%20advanced%20prostate%20cancer.%20Proc%20Natl%20Acad%20Sci%20USA%20116(23):11428%E2%80%9311436" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Hornberg E et al (2011) Expression of androgen receptor splice variants in prostate Cancer bone metastases is associated with castration-resistance and short survival. PLoS ONE 6(4):e19059
</cite> [<a href="https://doi.org/10.1371/journal.pone.0019059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3084247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21552559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hornberg%20E%20et%20al%20(2011)%20Expression%20of%20androgen%20receptor%20splice%20variants%20in%20prostate%20Cancer%20bone%20metastases%20is%20associated%20with%20castration-resistance%20and%20short%20survival.%20PLoS%20ONE%206(4):e19059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Labrecque MP et al (2019) Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. J Clin Invest 129(10):4492–4505
</cite> [<a href="https://doi.org/10.1172/JCI128212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6763249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31361600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Labrecque%20MP%20et%20al%20(2019)%20Molecular%20profiling%20stratifies%20diverse%20phenotypes%20of%20treatment-refractory%20metastatic%20castration-resistant%20prostate%20cancer.%20J%20Clin%20Invest%20129(10):4492%E2%80%934505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Nordstrand A et al (2018) Bone cell activity in clinical prostate cancer bone metastasis and its inverse relation to tumor cell androgen receptor activity. Int J Mol Sci 19(4):1223
</cite> [<a href="https://doi.org/10.3390/ijms19041223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5979457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29670000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nordstrand%20A%20et%20al%20(2018)%20Bone%20cell%20activity%20in%20clinical%20prostate%20cancer%20bone%20metastasis%20and%20its%20inverse%20relation%20to%20tumor%20cell%20androgen%20receptor%20activity.%20Int%20J%20Mol%20Sci%2019(4):1223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Quigley DA et al (2018) Genomic hallmarks and structural variation in metastatic prostate cancer. Cell 175(3):889
</cite> [<a href="https://doi.org/10.1016/j.cell.2018.10.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30340047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Quigley%20DA%20et%20al%20(2018)%20Genomic%20hallmarks%20and%20structural%20variation%20in%20metastatic%20prostate%20cancer.%20Cell%20175(3):889" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Roudier MP et al (2008) Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 180(3):1154–1160
</cite> [<a href="https://doi.org/10.1016/j.juro.2008.04.140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2992811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18639279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roudier%20MP%20et%20al%20(2008)%20Histopathological%20assessment%20of%20prostate%20cancer%20bone%20osteoblastic%20metastases.%20J%20Urol%20180(3):1154%E2%80%931160" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ylitalo EB et al (2017) Subgroups of Castration-resistant prostate Cancer bone metastases defined through an inverse relationship between androgen receptor activity and immune response (71, Pg 776, 2017). Eur Urol 72(5):E147–E</cite> [<a href="https://doi.org/10.1016/j.eururo.2016.07.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27497761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ylitalo%20EB%20et%20al%20(2017)%20Subgroups%20of%20Castration-resistant%20prostate%20Cancer%20bone%20metastases%20defined%20through%20an%20inverse%20relationship%20between%20androgen%20receptor%20activity%20and%20immune%20response%20(71,%20Pg%20776,%202017).%20Eur%20Urol%2072(5):E147%E2%80%93E" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ylitalo EB et al (2021) A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer. Clin Epigenetics 13(1):133
</cite> [<a href="https://doi.org/10.1186/s13148-021-01119-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8244194/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34193246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ylitalo%20EB%20et%20al%20(2021)%20A%20novel%20DNA%20methylation%20signature%20is%20associated%20with%20androgen%20receptor%20activity%20and%20patient%20prognosis%20in%20bone%20metastatic%20prostate%20cancer.%20Clin%20Epigenetics%2013(1):133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>You S et al (2016) Integrated classification of prostate Cancer reveals a novel luminal subtype with poor outcome. Cancer Res 76(17):4948–4958
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-0902" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5047668/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27302169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?You%20S%20et%20al%20(2016)%20Integrated%20classification%20of%20prostate%20Cancer%20reveals%20a%20novel%20luminal%20subtype%20with%20poor%20outcome.%20Cancer%20Res%2076(17):4948%E2%80%934958" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Zhao SG et al (2017) Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy. JAMA Oncol 3(12):1663–1672
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0751" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5824281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28494073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20SG%20et%20al%20(2017)%20Associations%20of%20luminal%20and%20basal%20subtyping%20of%20prostate%20cancer%20with%20prognosis%20and%20response%20to%20androgen%20deprivation%20therapy.%20JAMA%20Oncol%203(12):1663%E2%80%931672" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Bedeschi M et al (2023) Cancer-associated fibroblast: role in prostate cancer progression to metastatic disease and therapeutic resistance. Cells 12:5</cite> [<a href="https://doi.org/10.3390/cells12050802" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10000679/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36899938/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Ge R, Wang Z, Cheng L (2022) Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance. NPJ Precis Oncol 6(1):31
</cite> [<a href="https://doi.org/10.1038/s41698-022-00272-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9068628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35508696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ge%20R,%20Wang%20Z,%20Cheng%20L%20(2022)%20Tumor%20microenvironment%20heterogeneity%20an%20important%20mediator%20of%20prostate%20cancer%20progression%20and%20therapeutic%20resistance.%20NPJ%20Precis%20Oncol%206(1):31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Hagglof C, Bergh A (2012) The stroma-a key regulator in prostate function and malignancy. Cancers (Basel) 4(2):531–548
</cite> [<a href="https://doi.org/10.3390/cancers4020531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3712705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24213323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hagglof%20C,%20Bergh%20A%20(2012)%20The%20stroma-a%20key%20regulator%20in%20prostate%20function%20and%20malignancy.%20Cancers%20(Basel)%204(2):531%E2%80%93548" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Levesque C, Nelson PS (2018) Cellular constituents of the prostate stroma: key contributors to prostate cancer progression and therapy resistance. Cold Spring Harb Perspect Med 8(8):a030510
</cite> [<a href="https://doi.org/10.1101/cshperspect.a030510" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5681439/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28490538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Levesque%20C,%20Nelson%20PS%20(2018)%20Cellular%20constituents%20of%20the%20prostate%20stroma:%20key%20contributors%20to%20prostate%20cancer%20progression%20and%20therapy%20resistance.%20Cold%20Spring%20Harb%20Perspect%20Med%208(8):a030510" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Owen JS, Clayton A, Pearson HB (2022) Cancer-Associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules 13:1
</cite> [<a href="https://doi.org/10.3390/biom13010067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9856041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36671452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Owen%20JS,%20Clayton%20A,%20Pearson%20HB%20(2022)%20Cancer-Associated%20fibroblast%20heterogeneity,%20activation%20and%20function:%20implications%20for%20prostate%20cancer.%20Biomolecules%2013:1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Pederzoli F et al (2023) Stromal cells in prostate cancer pathobiology: Friends or foes? Br J Cancer 128(6):930–939
</cite> [<a href="https://doi.org/10.1038/s41416-022-02085-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10006214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36482187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pederzoli%20F%20et%20al%20(2023)%20Stromal%20cells%20in%20prostate%20cancer%20pathobiology:%20Friends%20or%20foes?%20Br%20J%20Cancer%20128(6):930%E2%80%93939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Baryawno N et al (2019) A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177(7):1915–1932 e16
</cite> [<a href="https://doi.org/10.1016/j.cell.2019.04.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6570562/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31130381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baryawno%20N%20et%20al%20(2019)%20A%20cellular%20taxonomy%20of%20the%20bone%20marrow%20stroma%20in%20homeostasis%20and%20leukemia.%20Cell%20177(7):1915%E2%80%931932%20e16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Kfoury Y et al (2021) Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell 39(11):1464–78e8
</cite> [<a href="https://doi.org/10.1016/j.ccell.2021.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8578470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34719426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kfoury%20Y%20et%20al%20(2021)%20Human%20prostate%20cancer%20bone%20metastases%20have%20an%20actionable%20immunosuppressive%20microenvironment.%20Cancer%20Cell%2039(11):1464%E2%80%9378e8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Hagglof C et al (2014) TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS ONE 9(2):e86824
</cite> [<a href="https://doi.org/10.1371/journal.pone.0086824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3914792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24505269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hagglof%20C%20et%20al%20(2014)%20TMPRSS2-ERG%20expression%20predicts%20prostate%20cancer%20survival%20and%20associates%20with%20stromal%20biomarkers.%20PLoS%20ONE%209(2):e86824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Abu EO et al (1997) The localization of androgen receptors in human bone. J Clin Endocrinol Metab 82(10):3493–3497
</cite> [<a href="https://doi.org/10.1210/jcem.82.10.4319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9329391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abu%20EO%20et%20al%20(1997)%20The%20localization%20of%20androgen%20receptors%20in%20human%20bone.%20J%20Clin%20Endocrinol%20Metab%2082(10):3493%E2%80%933497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mantalaris A et al (2001) Localization of androgen receptor expression in human bone marrow. J Pathol 193(3):361–366
</cite> [<a href="https://doi.org/10.1002/1096-9896(0000)9999:9999&lt;::AID-PATH803&gt;3.0.CO;2-W" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11241417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mantalaris%20A%20et%20al%20(2001)%20Localization%20of%20androgen%20receptor%20expression%20in%20human%20bone%20marrow.%20J%20Pathol%20193(3):361%E2%80%93366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Roudier MP et al (2003) Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 34(7):646–653
</cite> [<a href="https://doi.org/10.1016/s0046-8177(03)00190-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12874759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roudier%20MP%20et%20al%20(2003)%20Phenotypic%20heterogeneity%20of%20end-stage%20prostate%20carcinoma%20metastatic%20to%20bone.%20Hum%20Pathol%2034(7):646%E2%80%93653" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Barron DA, Rowley DR (2012) The reactive stroma microenvironment and prostate cancer progression. Endocr-Relat Cancer 19(6):R187–R204
</cite> [<a href="https://doi.org/10.1530/ERC-12-0085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3716392/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22930558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barron%20DA,%20Rowley%20DR%20(2012)%20The%20reactive%20stroma%20microenvironment%20and%20prostate%20cancer%20progression.%20Endocr-Relat%20Cancer%2019(6):R187%E2%80%93R204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Cunha GR, Baskin L (2018) Development of human male and female urogenital tracts. Differentiation 103:1–4
</cite> [<a href="https://doi.org/10.1016/j.diff.2018.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30262219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cunha%20GR,%20Baskin%20L%20(2018)%20Development%20of%20human%20male%20and%20female%20urogenital%20tracts.%20Differentiation%20103:1%E2%80%934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Toivanen R, Shen MM (2017) Prostate organogenesis: tissue induction, hormonal regulation and cell type specification. Development 144(8):1382–1398
</cite> [<a href="https://doi.org/10.1242/dev.148270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5399670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28400434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Toivanen%20R,%20Shen%20MM%20(2017)%20Prostate%20organogenesis:%20tissue%20induction,%20hormonal%20regulation%20and%20cell%20type%20specification.%20Development%20144(8):1382%E2%80%931398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Tyekucheva S et al (2017) Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer. Nat Commun 8(1):420
</cite> [<a href="https://doi.org/10.1038/s41467-017-00460-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5583238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28871082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tyekucheva%20S%20et%20al%20(2017)%20Stromal%20and%20epithelial%20transcriptional%20map%20of%20initiation%20progression%20and%20metastatic%20potential%20of%20human%20prostate%20cancer.%20Nat%20Commun%208(1):420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Jernberg E, Bergh A, Wikstrom P (2017) Clinical relevance of androgen receptor alterations in prostate cancer. Endocr Connect 6(8):R146–R61
</cite> [<a href="https://doi.org/10.1530/EC-17-0118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5640574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29030409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jernberg%20E,%20Bergh%20A,%20Wikstrom%20P%20(2017)%20Clinical%20relevance%20of%20androgen%20receptor%20alterations%20in%20prostate%20cancer.%20Endocr%20Connect%206(8):R146%E2%80%93R61" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Wikstrom P et al (2009) Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients. Prostate 69(8):799–809
</cite> [<a href="https://doi.org/10.1002/pros.20927" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19189305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wikstrom%20P%20et%20al%20(2009)%20Low%20stroma%20androgen%20receptor%20level%20in%20normal%20and%20tumor%20prostate%20tissue%20is%20related%20to%20poor%20outcome%20in%20prostate%20cancer%20patients.%20Prostate%2069(8):799%E2%80%93809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Nordstrand A et al (2017) Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone. Clin Exp Metastasis 34(3–4):261–271
</cite> [<a href="https://doi.org/10.1007/s10585-017-9848-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5442252/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28447314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nordstrand%20A%20et%20al%20(2017)%20Inhibition%20of%20the%20insulin-like%20growth%20factor-1%20receptor%20potentiates%20acute%20effects%20of%20castration%20in%20a%20rat%20model%20for%20prostate%20cancer%20growth%20in%20bone.%20Clin%20Exp%20Metastasis%2034(3%E2%80%934):261%E2%80%93271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Carlson P et al (2019) Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy. Nat Cell Biol 21(2):238–250
</cite> [<a href="https://doi.org/10.1038/s41556-018-0267-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6948102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30664790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carlson%20P%20et%20al%20(2019)%20Targeting%20the%20perivascular%20niche%20sensitizes%20disseminated%20tumour%20cells%20to%20chemotherapy.%20Nat%20Cell%20Biol%2021(2):238%E2%80%93250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Ghajar CM et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15(7):807–817
</cite> [<a href="https://doi.org/10.1038/ncb2767" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3826912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23728425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghajar%20CM%20et%20al%20(2013)%20The%20perivascular%20niche%20regulates%20breast%20tumour%20dormancy.%20Nat%20Cell%20Biol%2015(7):807%E2%80%93817" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Graham N, Qian BZ (2018) Mesenchymal stromal cells: emerging roles in bone metastasis. Int J Mol Sci 19:4</cite> [<a href="https://doi.org/10.3390/ijms19041121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5979535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29642534/" class="usa-link">PubMed</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Peinado H et al (2017) Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer 17(5):302–317
</cite> [<a href="https://doi.org/10.1038/nrc.2017.6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28303905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peinado%20H%20et%20al%20(2017)%20Pre-metastatic%20niches:%20organ-specific%20homes%20for%20metastases.%20Nat%20Rev%20Cancer%2017(5):302%E2%80%93317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Satcher RL, Zhang XH (2022) Evolving cancer-niche interactions and therapeutic targets during bone metastasis. Nat Rev Cancer 22(2):85–101
</cite> [<a href="https://doi.org/10.1038/s41568-021-00406-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10281546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34611349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Satcher%20RL,%20Zhang%20XH%20(2022)%20Evolving%20cancer-niche%20interactions%20and%20therapeutic%20targets%20during%20bone%20metastasis.%20Nat%20Rev%20Cancer%2022(2):85%E2%80%93101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Shiozawa Y et al (2016) The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer. Oncotarget 7(27):41217–41232
</cite> [<a href="https://doi.org/10.18632/oncotarget.9251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5173053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27172799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shiozawa%20Y%20et%20al%20(2016)%20The%20marrow%20niche%20controls%20the%20cancer%20stem%20cell%20phenotype%20of%20disseminated%20prostate%20cancer.%20Oncotarget%207(27):41217%E2%80%9341232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Chu GC et al (2019) Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian J Urol 6(1):65–81
</cite> [<a href="https://doi.org/10.1016/j.ajur.2018.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6363607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30775250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chu%20GC%20et%20al%20(2019)%20Regulatory%20signaling%20network%20in%20the%20tumor%20microenvironment%20of%20prostate%20cancer%20bone%20and%20visceral%20organ%20metastases%20and%20the%20development%20of%20novel%20therapeutics.%20Asian%20J%20Urol%206(1):65%E2%80%9381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Hensel J, Thalmann GN (2016) Biology of bone metastases in prostate Cancer. Urology 92:6–13
</cite> [<a href="https://doi.org/10.1016/j.urology.2015.12.039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26768714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hensel%20J,%20Thalmann%20GN%20(2016)%20Biology%20of%20bone%20metastases%20in%20prostate%20Cancer.%20Urology%2092:6%E2%80%9313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Ren G, Esposito M, Kang Y (2015) Bone metastasis and the metastatic niche. J Mol Med (Berl) 93(11):1203–1212
</cite> [<a href="https://doi.org/10.1007/s00109-015-1329-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4636917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26275789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ren%20G,%20Esposito%20M,%20Kang%20Y%20(2015)%20Bone%20metastasis%20and%20the%20metastatic%20niche.%20J%20Mol%20Med%20(Berl)%2093(11):1203%E2%80%931212" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Rossnagl S et al (2018) A subpopulation of stromal cells controls Cancer cell homing to the bone marrow. Cancer Res 78(1):129–142
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-3507" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29066511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rossnagl%20S%20et%20al%20(2018)%20A%20subpopulation%20of%20stromal%20cells%20controls%20Cancer%20cell%20homing%20to%20the%20bone%20marrow.%20Cancer%20Res%2078(1):129%E2%80%93142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Sowder ME, Johnson RW (2019) Bone as a preferential site for metastasis. JBMR Plus 3(3):e10126
</cite> [<a href="https://doi.org/10.1002/jbm4.10126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6419612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30918918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sowder%20ME,%20Johnson%20RW%20(2019)%20Bone%20as%20a%20preferential%20site%20for%20metastasis.%20JBMR%20Plus%203(3):e10126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Zheng H, Li W, Kang Y (2016) Tumor-Stroma interactions in bone metastasis: molecular mechanisms and therapeutic implications. Cold Spring Harb Symp Quant Biol 81:151–161
</cite> [<a href="https://doi.org/10.1101/sqb.2016.81.030775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28381439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20H,%20Li%20W,%20Kang%20Y%20(2016)%20Tumor-Stroma%20interactions%20in%20bone%20metastasis:%20molecular%20mechanisms%20and%20therapeutic%20implications.%20Cold%20Spring%20Harb%20Symp%20Quant%20Biol%2081:151%E2%80%93161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>von Moos R et al (2019) Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody. Cancer Treat Rev 76:57–67
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2019.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31136850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?von%20Moos%20R%20et%20al%20(2019)%20Management%20of%20bone%20health%20in%20solid%20tumours:%20from%20bisphosphonates%20to%20a%20monoclonal%20antibody.%20Cancer%20Treat%20Rev%2076:57%E2%80%9367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Ghajar CM (2015) Metastasis prevention by targeting the dormant niche. Nat Rev Cancer 15(4):238–247
</cite> [<a href="https://doi.org/10.1038/nrc3910" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4842412/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25801619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghajar%20CM%20(2015)%20Metastasis%20prevention%20by%20targeting%20the%20dormant%20niche.%20Nat%20Rev%20Cancer%2015(4):238%E2%80%93247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Franck-Lissbrant I et al (1998) Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139(2):451–456
</cite> [<a href="https://doi.org/10.1210/endo.139.2.5683" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9449610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Franck-Lissbrant%20I%20et%20al%20(1998)%20Testosterone%20stimulates%20angiogenesis%20and%20vascular%20regrowth%20in%20the%20ventral%20prostate%20in%20castrated%20adult%20rats.%20Endocrinology%20139(2):451%E2%80%93456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Lissbrant IF et al (2004) Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1–3)IgG inhibits testosterone-stimulated prostate growth in castrated mice. Prostate 58(1):57–65
</cite> [<a href="https://doi.org/10.1002/pros.10312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14673953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lissbrant%20IF%20et%20al%20(2004)%20Neutralizing%20VEGF%20bioactivity%20with%20a%20soluble%20chimeric%20VEGF-receptor%20protein%20flt(1%E2%80%933)IgG%20inhibits%20testosterone-stimulated%20prostate%20growth%20in%20castrated%20mice.%20Prostate%2058(1):57%E2%80%9365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Song HB et al (2022) Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell States. Nat Commun 13:1
</cite> [<a href="https://doi.org/10.1038/s41467-021-27322-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8748675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35013146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Song%20HB%20et%20al%20(2022)%20Single-cell%20analysis%20of%20human%20primary%20prostate%20cancer%20reveals%20the%20heterogeneity%20of%20tumor-associated%20epithelial%20cell%20States.%20Nat%20Commun%2013:1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Vickman RE et al (2020) Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment. Prostate 80(2):173–185
</cite> [<a href="https://doi.org/10.1002/pros.23929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12004274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31763714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vickman%20RE%20et%20al%20(2020)%20Heterogeneity%20of%20human%20prostate%20carcinoma-associated%20fibroblasts%20implicates%20a%20role%20for%20subpopulations%20in%20myeloid%20cell%20recruitment.%20Prostate%2080(2):173%E2%80%93185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Yu X et al (2023) Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment. Cell Mol Biol Lett 28(1):38
</cite> [<a href="https://doi.org/10.1186/s11658-023-00450-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10170780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37161356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20X%20et%20al%20(2023)%20Single-cell%20omics%20traces%20the%20heterogeneity%20of%20prostate%20cancer%20cells%20and%20the%20tumor%20microenvironment.%20Cell%20Mol%20Biol%20Lett%2028(1):38" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Price TT, Sipkins DA (2017) E-Selectin and SDF-1 regulate metastatic trafficking of breast cancer cells within the bone. Mol Cell Oncol 4(4):e1214771
</cite> [<a href="https://doi.org/10.1080/23723556.2016.1214771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5540205/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28868340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Price%20TT,%20Sipkins%20DA%20(2017)%20E-Selectin%20and%20SDF-1%20regulate%20metastatic%20trafficking%20of%20breast%20cancer%20cells%20within%20the%20bone.%20Mol%20Cell%20Oncol%204(4):e1214771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Cattrini C et al (2018) Overexpression of Periostin in tumor biopsy samples is associated with prostate Cancer phenotype and clinical outcome. Clin Genitourin Cancer 16(6):e1257–e65
</cite> [<a href="https://doi.org/10.1016/j.clgc.2018.07.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30170989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cattrini%20C%20et%20al%20(2018)%20Overexpression%20of%20Periostin%20in%20tumor%20biopsy%20samples%20is%20associated%20with%20prostate%20Cancer%20phenotype%20and%20clinical%20outcome.%20Clin%20Genitourin%20Cancer%2016(6):e1257%E2%80%93e65" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Tian Y et al (2015) Overexpression of periostin in stroma positively associated with aggressive prostate cancer. PLoS ONE 10(3):e0121502
</cite> [<a href="https://doi.org/10.1371/journal.pone.0121502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4362940/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25781169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tian%20Y%20et%20al%20(2015)%20Overexpression%20of%20periostin%20in%20stroma%20positively%20associated%20with%20aggressive%20prostate%20cancer.%20PLoS%20ONE%2010(3):e0121502" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Edwards IJ (2012) Proteoglycans in prostate cancer. Nat Rev Urol 9(4):196–206
</cite> [<a href="https://doi.org/10.1038/nrurol.2012.19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22349653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Edwards%20IJ%20(2012)%20Proteoglycans%20in%20prostate%20cancer.%20Nat%20Rev%20Urol%209(4):196%E2%80%93206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Henke A et al (2012) Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer. PLoS ONE 7(8):e42516
</cite> [<a href="https://doi.org/10.1371/journal.pone.0042516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3411755/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22880013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Henke%20A%20et%20al%20(2012)%20Stromal%20expression%20of%20decorin,%20Semaphorin6D,%20SPARC,%20Sprouty1%20and%20Tsukushi%20in%20developing%20prostate%20and%20decreased%20levels%20of%20decorin%20in%20prostate%20cancer.%20PLoS%20ONE%207(8):e42516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Montano M et al (2018) Dual regulation of decorin by androgen and Hedgehog signaling during prostate morphogenesis. Dev Dyn 247(5):679–685
</cite> [<a href="https://doi.org/10.1002/dvdy.24619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29368411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montano%20M%20et%20al%20(2018)%20Dual%20regulation%20of%20decorin%20by%20androgen%20and%20Hedgehog%20signaling%20during%20prostate%20morphogenesis.%20Dev%20Dyn%20247(5):679%E2%80%93685" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Hu Y et al (2009) Decorin suppresses prostate tumor growth through Inhibition of epidermal growth factor and androgen receptor pathways. Neoplasia 11(10):1042–1053
</cite> [<a href="https://doi.org/10.1593/neo.09760" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2745670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19794963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Y%20et%20al%20(2009)%20Decorin%20suppresses%20prostate%20tumor%20growth%20through%20Inhibition%20of%20epidermal%20growth%20factor%20and%20androgen%20receptor%20pathways.%20Neoplasia%2011(10):1042%E2%80%931053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Neill T, Schaefer L, Iozzo RV (2016) Decorin as a multivalent therapeutic agent against cancer. Adv Drug Deliv Rev 97:174–185
</cite> [<a href="https://doi.org/10.1016/j.addr.2015.10.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4753134/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26522384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neill%20T,%20Schaefer%20L,%20Iozzo%20RV%20(2016)%20Decorin%20as%20a%20multivalent%20therapeutic%20agent%20against%20cancer.%20Adv%20Drug%20Deliv%20Rev%2097:174%E2%80%93185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Jarvelainen H, Sainio A, Wight TN (2015) Pivotal role for decorin in angiogenesis. Matrix Biol 43:15–26
</cite> [<a href="https://doi.org/10.1016/j.matbio.2015.01.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4560244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25661523/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jarvelainen%20H,%20Sainio%20A,%20Wight%20TN%20(2015)%20Pivotal%20role%20for%20decorin%20in%20angiogenesis.%20Matrix%20Biol%2043:15%E2%80%9326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Jarvinen TA, Prince S (2015) Decorin: a growth factor antagonist for tumor growth inhibition. Biomed Res Int 2015:654765</cite> [<a href="https://doi.org/10.1155/2015/654765" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4677162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26697491/" class="usa-link">PubMed</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Xu W et al (2015) The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer. Gene Ther 22(3):247–256
</cite> [<a href="https://doi.org/10.1038/gt.2014.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4361227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25503693/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20W%20et%20al%20(2015)%20The%20systemic%20delivery%20of%20an%20oncolytic%20adenovirus%20expressing%20decorin%20inhibits%20bone%20metastasis%20in%20a%20mouse%20model%20of%20human%20prostate%20cancer.%20Gene%20Ther%2022(3):247%E2%80%93256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Ammirante M et al (2010) B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 464(7286):302–305
</cite> [<a href="https://doi.org/10.1038/nature08782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2866639/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20220849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ammirante%20M%20et%20al%20(2010)%20B-cell-derived%20lymphotoxin%20promotes%20castration-resistant%20prostate%20cancer.%20Nature%20464(7286):302%E2%80%93305" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Sciarra F et al (2023) Gender-specific impact of sex hormones on the immune system. Int J Mol Sci 24:7</cite> [<a href="https://doi.org/10.3390/ijms24076302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10094624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37047274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sciarra%20F%20et%20al%20(2023)%20Gender-specific%20impact%20of%20sex%20hormones%20on%20the%20immune%20system.%20Int%20J%20Mol%20Sci%2024:7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Zhu P et al (2006) Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124(3):615–629
</cite> [<a href="https://doi.org/10.1016/j.cell.2005.12.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16469706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20P%20et%20al%20(2006)%20Macrophage/cancer%20cell%20interactions%20mediate%20hormone%20resistance%20by%20a%20nuclear%20receptor%20derepression%20pathway.%20Cell%20124(3):615%E2%80%93629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Berglund E et al (2018) Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nat Commun 9(1):2419
</cite> [<a href="https://doi.org/10.1038/s41467-018-04724-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6010471/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29925878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berglund%20E%20et%20al%20(2018)%20Spatial%20maps%20of%20prostate%20cancer%20transcriptomes%20reveal%20an%20unexplored%20landscape%20of%20heterogeneity.%20Nat%20Commun%209(1):2419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Chen SJ et al (2021) Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat Cell Biol 23:1</cite> [<a href="https://doi.org/10.1038/s41556-020-00613-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33420488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20SJ%20et%20al%20(2021)%20Single-cell%20analysis%20reveals%20transcriptomic%20remodellings%20in%20distinct%20cell%20types%20that%20contribute%20to%20human%20prostate%20cancer%20progression.%20Nat%20Cell%20Biol%2023:1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Marklund M et al (2022) Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones. Nat Commun 13(1):5475
</cite> [<a href="https://doi.org/10.1038/s41467-022-33069-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9482614/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36115838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marklund%20M%20et%20al%20(2022)%20Spatio-temporal%20analysis%20of%20prostate%20tumors%20in%20situ%20suggests%20pre-existence%20of%20treatment-resistant%20clones.%20Nat%20Commun%2013(1):5475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>MacDonald WJ et al (2025) Heterogeneity in cancer. Cancers (Basel) 173</cite> [<a href="https://doi.org/10.3390/cancers17030441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11816170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39941808/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12370827/bin/10585_2025_10365_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (1MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Clinical &amp; Experimental Metastasis are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s10585-025-10365-y"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/10585_2025_Article_10365.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370827/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370827/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370827%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370827/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370827/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370827/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841830/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370827/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841830/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370827/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370827/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="I9ackrLjXEdvNuEGYC88OfQrNsUTGP3369k1VsHU0upnayvatFzRt4mf5oOelQ9y">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
